| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | -0.048 | 0.1 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | -0.047 | 0.1 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.2 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | 0.048 | 0.2 |